baber/WOPTO huggingface dataset:
Patent FI-953169-A0 (FI)
Inventor: FERDINANDSEN ALEXANDER MILAN
IPC: B41M3/06
Filed: 1995-06-27
Abstract: PCT No. PCT/DK94/00019 Sec. 371 Date Sep. 14, 1994 Sec. 102(e) Date Sep. 14, 1994 PCT Filed Jan. 11, 1994 PCT Pub. No. WO94/15800 PCT Pub. Date Jul. 21, 1994A mask is adapted for superimposing on a photograph to accentuate a portion of the photograph. The mask is made of a thin sheet of plastic, by means of, e.g., colored raster which is opaque in a periopheral region surrounding a transparent, central area without raster. The peripheral region and the central area are separated by a relatively narrow, transitional zone with increasing distance between the raster, so that the transitional zone gradually fades out into the transparent, central area. The mask may be employed in the same simple manner as a passe-partout frame for accentuating one particular portion of a photograph, and with the same good visual effect achieved by a traditional phototechnical method for integrally providing a photograph with a neutral peripheral region gradually fading out via a soft transitional zone into the desired portion of the photograph.
Patent FI-955581-A0 (FI)
Inventor: ZAGDOUN GEORGES
IPC: B32B7/02
Filed: 1995-11-20
Abstract: Glazing prod. comprises a transparent substrate (1) e.g. of glass covered with at least 1 thin layer (4) comprising a mixed oxide of Si, Al and an element M that facilitates the formation of a homogeneous mixed oxide of Si and Al. The oxide layer (4) is of a mixed oxide of formula: SiAlxOyMzM'u (where, M = F; M' = C; x = 0.06-0.74 (0.14-0.33); y = 2.1-3.1 (2.3-2.5); z = 0.02-0.15 (0.04-0.08) and u = 0-0.15 (0.03-0.04)).
Patent FI-956026-A0 (FI)
Inventor: HARTIG KLAUS W
IPC: E04B1/76
Filed: 1995-12-14
Abstract: A sputter-coated glass article (1) comprised of a glass substrate having sputtered thereon (from the glass outwardly): (a) a layer of Si3N4 of 450-600Å thickness (3); (b) a layer of Ni or nichrome of 7Å thickness or less (4a); (c) a layer of Ag of 115-190Å thickness (5); (d) a layer of Ni or nichrome of 7Å thickness or less (4b); and (e) a layer of Si3N4 of 580-800Å thickness (7), where the glass substrate is 2-6 mm thick. The coated glass substrate has a visible transmittance of at least 70%, a normal emissivity (En) of less than 0.07, a hemispherical emissivity (Eh) of less than 0.075, a sheet resistance (Rs) of less than 5.5 ohms/sq and having the following colour co-ordinates where the glass side characteristics are: RgY is 12-19, ah is -3 to +3, bh is -5 to -20, and where the film side characteristics are: RfY is 8-12, ah is 0-6, bh is -5 to -30 film, where RY is the reflectance and ah and bh are colour co-ordinates as measured in Hunter units III., C., 10[deg] observer.
Patent FI-971201-A0 (FI)
Inventor: ALMEN TORSTEN
IPC: C07C275/42
Filed: 1997-03-21
Abstract: The invention provides low viscosity iodinated aryl compounds, useful as X-ray contrast agents, of formula I    <IMAGE>  (I)  (wherein n is 0 or 1, and where n is 1 each C6R5 moeity may be the same or different; each group R is a hydrogen atom, an iodine atom or a hydrophilic moiety M or M1, two or three non-adjacent R groups in each C6R5 moiety being iodine and at least one, and preferably two or three, R groups in each C6R5 moiety being M or M1 moieties; X denotes a bond or a group providing a 1 to 7 atom chain linking two C6R5 moieties or, where n is 0, X denotes a group R; each M independently is a non-ionic hydrophilic moiety; and each M1 independently represents a C1-4alkyl group substituted by at least one hydroxyl group and optionally linked to the phenyl ring via a carbonyl, sulphone or sulphoxide group, at least one R group being an M1 moiety; with the proviso that where n is zero either at least one M1 group other than a hydroxymethyl or 1,2-dihydroxyethyl group is present or then if one hydroxymethyl or 1,2-dihydroxyethyl M1 group is present at least one nitrogen-attached or hydroxylated-C3-4 alkyl moiety-containing M group is also present) and isomers thereof.
Patent FI-991163-A0 (FI)
Inventor: SUN HOI CHEONG STEAVE
IPC: B01J19/00
Filed: 1999-05-21
Abstract: The chuck (180) comprises an upper chuck face (110), which may be glass of 10-20 mm thick, and has through holes or passages (120) of diameters between approx. 50 mu m and approx. 75 mu m connected to a cavity (130) in a base (140). The base has an opening (150) for connection to a vacuum source (160), which imparts a negative pressure to the passages in the chuck face. - Beads (170) having an average diameter less than approx. 3 mm poured onto the chuck face are held by the negative pressure, through the application of a vacuum, onto a selected configuration of through holes. The beads may alternatively be attracted electrostatically to the chuck.
Patent AP-9801172-A0 (AP)
Title: Urinal.
Inventor: LA TROBE BRIAN ESSEX
Filed: 1998-01-06
Abstract: An evaporation unit for one or more urinals includes a chamber housing at least one series of downwardly inclined troughs extending across the chamber to overflow from one to the next, a vent pipe and a wall panel for the chamber designed to generate heat within the chamber and vent and an air inlet into the lower part of the chamber below the troughs.
Patent IL-57376-A0 (IL)
Title: Energy conversion method and system
IPC: F24V30/00
Filed: 1979-05-23
Abstract: A mechanical energy conversion method and system for the restoration of dissipated heat energy, contained in natural or artificial water bodies at or near ambient temperatures, to industrial process heat, mainly in the form of steam up to 200 DEG -400 DEG  C. The sensible heat contained in a water body is concentrated as latent heat in low pressure water vapor which is thermo-compressed by steam ejection to an intermediate pressure level, wherefrom mechanical compression takes over, generating highly superheated output steam. The ejecting steam is not generated in a boiler, but is continuously regenerated by the compressor and routed back for repeated ejection. The compressor is driven by a heat engine whose reject heat is collected and upgraded as well. The output of heat energy is essentially equal to the sum of the heating value of the fuel consumed and the intake of latent heat and amounts thus to substantially more than the heating value of the fuel alone.
Patent IL-60751-A0 (IL)
Title: Substituted pyranone derivatives,their preparation and pharmaceutical compositions containing them
IPC: A61P3/06
Filed: 1980-08-04
Abstract: 6-Phenyl, phenalkyl- and phenylethenyl-4-hydroxytetrahydropyran-2-ones in the 4- R trans stereoisomeric forms having the structure <CHEM>  wherein  A is H or methyl;  E is a direct bond, -CH2-, -CH2-CH2-, -CH2-CH2-CH2- or -CH=CH-; and  R1, R2 and R3 have several meanings, and the corresponding dihydroxy acids in which the lactone ring is hydrolytically opened, and the pharmaceutically acceptable salts of said dihydroxy acids, and the lower alkyl and the phenyl, dimethylamino or acetylamino-substituted  lower alkyl esters of said dihydroxy acids; and processes for preparing  them. These compounds are potent inhibitors of cholesterol synthesis by the enzyme hydroxymethyl glutaryl coenzyme A reductase.
Patent IL-61163-A0 (IL)
Title: 3-(2,3-dichloro-3,3-difluoro-prop-1-en-1-yl)-2,2-dimethyl-cyclopropanecarboxylic acid fluoro-benzyl esters,their preparation and their use as pesticides
IPC: C07C67/14
Filed: 1980-09-29
Abstract: 3-(2,3-Dichloro-3,3-difluoro-prop-1-en-1-yl)-2,2-dimethyl-cyclo-propan ecarboxylic acid fluoro-benzyl esters of the formula   <IMAGE>   in which R1 represents hydrogen, cyano, alkyl with up to 4 carbon atoms, alkenyl with up to 4 carbon atoms or alkynyl with up to 4 carbon atoms, and R2 represents a phenyl radical which is substituted by fluorine and/or optionally fluorine-substituted phenoxy, with the proviso that the radical R2 in total contains at least one fluorine substituent, which possess pesticidal activity.
Patent IL-79196-A0 (IL)
Title: Tetramethylcyclopropanecarboxylate derivatives,their preparation and their use in combating pests
IPC: C07C317/22
Filed: 1986-06-23
Abstract: Pesticidal compositions useful in protecting plants and also in the hygiene field are disclosed. The new tetramethylcyclopropanecarboxylates have the formula   <IMAGE> where R represents mercapto, methylthio, alkylsulphenyl or alkylsulphonyl.
Patent IL-79403-A0 (IL)
Title: Production of dry,bioactive recombinant growth hormones
IPC: A61K35/74
Filed: 1986-07-14
Abstract: The present invention provides improved controlled release implants for subcutaneous administration to an animal of a growth promoting amount of a recombinant protein having growth hormone activity, characterised in that said protein is present in a form having a salt content of less than 5% by weight based on the weight of said protein.
Patent IL-85208-A0 (IL)
Title: Method and apparatus for treating fresh vegetable products
IPC: A23B7/022
Filed: 1988-01-26
Abstract: A method and apparatus for treating fresh harvested vegetable products such as herbs and spices includes a conveyor system for moving the product from a supply to a chilled water washing station which includes a drain portion; at a second station the product is steeped in a solution of citric and ascorbic or erythorbic acid and then drained; the product is then dried quickly at a third station in a fluidized bed dryer and then passed to heated huxectant bath at a fifth station and then drained again; at a sixth station, the product is rapidly cooled in a cooling chamber; at a seventh station the product may be destemmed and then chopped and packaged.
Patent IL-89015-A0 (IL)
Title: Tetrahydropyridine derivatives,their preparation and pharmaceutical compositions containing them
IPC: A61P43/00
Filed: 1989-01-20
Abstract: Novel tetrahydropyridine derivatives, processes for their preparation and use as medicaments having cholinomimetic properties.
Patent IL-89874-A0 (IL)
Title: Apparatus for computerized laser surgery
IPC: A61B18/20
Filed: 1989-04-06
Abstract: There is provided an apparatus and methods for computerized laser surgery. The apparatus comprises apparatus for displaying in real time a visually sensible image of the area of surgery, apparatus for displaying in overlay over the visually sensible image a simulation of the effects of operator indicated laser surgical procedures on the area of surgery and automated apparatus for carrying out the operator indicated laser surgical procedures following the display thereof. The method includes the steps of simulating the effects of operator indicated laser surgical procedures on an area of surgery, tuning parameters of a beam of a surgical laser, aiming the apparatus for transmitting laser energy at each point of the surgery, low energy firing of the low energy laser beam at an operator indicated surgery point thereby to ensure that the surgical laser is correctly aimed and high energy firing of the surgical laser at the operator indicated surgery point thereby to treat the point.
Patent IL-93283-A0 (IL)
Title: Mixture of assistants and its use in the dyeing of synthetic fibre material
IPC: D06P1/613
Filed: 1990-02-06
Abstract: Dyeing auxiliary mixture containing
 (A) an acid ester or its salts of an alkylene oxide adduct of the formula 
<IMAGE>
 in which V denotes hydrogen or methyl,
 X denotes the acid radical of an inorganic acid containing oxygen or the radical of an organic acid and
 Y denotes C1-C12-alkyl, aryl or aralkyl,
 "alkylene" stands for the ethylene radical or propylene radical and
 m is 1 to 3, m1 is 1 or 2 and n is 4 to 50,
 (B) a non-ionic surfactant containing polyglycol ether groups and
 (C) an aliphatic or aromatic carboxylic acid ester, an alkylbenzene, tetralin or a mixture of these substances. 
<??>The auxiliary mixture is employed in the dyeing of synthetic fibrous materials, in particular textile material containing polyester fibres, to increase the migration rate of disperse dyes.
Patent IL-97067-A0 (IL)
Title: Substrate-limited doughs
IPC: A21D6/00
Filed: 1991-01-28
Abstract: A dough for the preparation of yeast-leavened flour products is provided whereby the dough comprises yeast and an amount of sugar(s) fermentable by the yeast and wherein the maximal amount of CO2 gas produced during the proof is controlled and limited by the amount of fermentable sugar(s) present in the dough.
Patent IL-99701-A0 (IL)
Title: Indole derivatives
IPC: A61K31/404
Filed: 1991-10-09
Abstract: Compounds of formula (I), wherein n is 0, 1 or 2; R1 is hydrogen; R2 is selected from hydrogen, halogen, cyano, OR4, -(CH2)m-(C=O)NR5R6, -(CH2)m-SO2NR5R6, -(CH2)m-NR7(C=O)R8, -(CH2)m-NR7SO2R8, -(CH2)m-S(O)xR8, -(CH2)m-NR7(C=O)NR5R6, -(CH2)m-NR7(C=O)OR9, and -CH=CH(CH2)yR10; R3 is selected from hydrogen and C1 to C6 linear or branched alkyl; R4 is selected from hydrogen, C1 to C6 alkyl, and aryl; R5 and R6 are independently selected from hydrogen, C1 to C6 alkyl, aryl, and C1 to C3 alkyl-aryl or R5 and R6 taken together to form a 4, 5, or 6 membered ring; R7 and R8 are independently selected from hydrogen, C1 to C6 alkyl, aryl, and C1 to C3 alkyl-aryl; R9 is selected from hydrogen, C1 to C6 alkyl, aryl, and C1 to C3 alkyl-aryl R10 is selected from -(C=O)NR5R6 and -SO2NR5R6, wherein R5 and R6 are defined as above, and -NR7(C=O)R8, -NR7SO2R8, -NR7(C=O)NR5R6, -S(O)xR8 and -NR7(C=O)OR9, wherein R7, R8, and R9 are as defined above; y is 0, 1, or 2; x is 1 or 2; m is 0, 1, 2, or 3; and the above aryl groups and the aryl moieties of the above alkylaryl groups are independently selected from phenyl and substituted phenyl, wherein said substituted phenyl may be substituted with one to three groups selected from C1 to C4 alkyl, halogen, hydroxy, cyano, carboxamido, nitro, and C1 to C4 alkoxy and the pharmaceutically acceptable salts thereof are new. These compounds are useful psychotherapeutics and are potent serotonin (5-HT1) agonists and may be used in the treatment of depression, anxiety, eating disorders, obesity, drug abuse, cluster headache, migraine, pain, chronic paroxysmal hemicrania and headache associated with vascular disorders, and other disorders arising from deficient serotonergic neurotransmission. The compounds can also be used as centrally acting antihypertensives and vasodilators.
Patent AU-PO347396-A0 (AU)
Title: Synergistic gold-containing compositions
IPC: A61P17/00
Filed: 1996-11-04
Abstract: This invention relates to a method of treating an immune-mediated disorder having one or more manifestations. The method comprises administering to a patient requiring such treatment a gold compound and at least one corticosteroid, wherein the at least one corticosteroid is selected to interact synergistically with the gold compound to exhibit preferential action towards one of the manifestations of said disorder or to exhibit equal action towards each manifestation of said disorder. The invention also relates to a pharmaceutical composition suitable for use in the method.
Patent FI-20001696-A0 (FI)
Inventor: SEPPAELAE JUKKA VELI
IPC: A61L27/54
Filed: 2000-07-21
Abstract: The invention relates to a heterophasic composition which essentially consists of three immiscible components, A, B and C, and the production method of the same. The component A is some body compatible polymer, the component B is a water soluble or hydrolytically degradable substance which produces cavities or network like porosity after disappearing through solubilization or degradation, and a bioactive substance C which at least component B contains in form of particles as a blend component and which still exists in the pores or their walls after the degradation or solubilization of the component B. The materials according to the invention are biocommpatible, solid in normal temperatures, mechanically processable, and thermally mouldable as well as bioactive in the sense that they have the capability to renew different kinds of tissues in the body, on the surface of the living organisms, in the cavities of the body and in the tissue engineering conditions outside the body, and that they can be used in tissue engineering , in tissue regeneration, in healing of damaged or lacking tissues, in tissue guiding when treating deficiencies, in controlled drug release, in the treatment methods of dentistry, in orthopedics and in plastic surgery.
Patent IL-103040-A0 (IL)
Title: Heterocyclically substituted quinolylmethoxy-phenylacetamides,their preparation and pharmaceutical compositions containing them
IPC: A61P7/02
Filed: 1992-09-03
Abstract: Quinolylmethoxyphenylacetamides substituted by heterocycles are prepared by amidation of corresponding carboxylic acids. The compounds can be used in pharmaceutical compositions, in particular with lipoxygenase inhibiting action.
Patent IL-103171-A0 (IL)
Title: Composition for introducing nucleic acid complexes into higher eucaryotic cells
IPC: C07K16/28
Filed: 1992-09-15
Abstract: Composition for the transfection of higher eukaryotic cells with a complex of nucleic acid and substance which has affinity for nucleic acids and is optionally conjugated with an internalisation factor for these cells. The composition contains an endosomolytic agent which is either a free or a bound virus or a virus component or a viral or non-viral peptide with endosomolytic properties. <IMAGE>
Patent IL-106453-A0 (IL)
Title: Deoxy taxols and pharmaceutical compositions containing them
IPC: C07F9/655
Filed: 1993-07-22
Abstract: <CHEM>      in which   R<1> is   -COR<z> in which R<z> is RO- or R; R<g> is   C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-6 cycloalkyl, or a radical of the formula -W-R<x> in which W is a bond, C2-6 alkenediyl, or -(CH2)t-, in which t is one to six; and R<x> is naphthyl, phenyl, or heteroaryl, and furthermore R<x> can be optionally substituted with one to three same or different C1-6 alkyl, C1-6 alkoxy, halogen or -CF3 groups; R<2> is   -OCOR, H, OH, -OR, -OSO2R, -OCONR<o>R, -OCONHR, -OCOO(CH2)tR, or -OCOOR; and R and R<o>   are independently C1-6 alkyl, C2-6 alkenyl, C3-6 cycloalkyl, C2-6 alkynyl, or phenyl, optionally substituted with one to three same or different C1-6 alkyl, C1-6 alkoxy, halogen or -CF3 groups.   Further provided by this invention are pharmaceutical formulations and intermediates for the the preparation of deoxy taxols of formula I. A method of treating mammalian tumors using a compound of formula I is also provided.
Patent IL-107887-A0 (IL)
Title: Stabilized lanthionine containing bacteriocin compositions
IPC: A01N63/50
Filed: 1993-12-06
Abstract: The invention concerns compositions containing a lanthionine containing bacteriocin such as nisin which are stabilized by the presence of a thioether stabilizing agent against degradation.
Patent IL-119548-A0 (IL)
Title: Non-reducing saccharide
IPC: A61K31/02
Filed: 1993-12-22
Abstract: A method for purifying trehalose is provided. The method comprises:       (a) providing an aqueous trehalose solution; (b) concentrating the aqueous trehalose solution to crystallize trehalose; and (c) separating and collecting the crystallized crystalline trehalose hydrate.   <MATH>
Patent IL-131432-A0 (IL)
Title: Diagnostic apparatus
IPC: A61B5/00
Filed: 1998-02-27
Abstract: Medical sensors (1 to 4) are connected to a processor (6) comprising a PC and modems (14 and 16). The modems are connected to respective low power transmitter/receivers (18 and 20) The transmitter/receivers (18, 20) communicate with corresponding receiver/transmitters (18', 20') connected to a long range transmitter/receiver such as a satellite communications link (22, 23, 24). An operator of the apparatus has a hands free headset comprising a microphone (7) and earpieces (8), and has a head-up display (10). An electronic camera may also be provided. Medical data from the sensors (1-4) and images from the camera (9) and voice signals from the microphone (7) are processed by the processor (6), and transmitted to a remote location (B), for use by a doctor having a corresponding processor and display to diagnose the condition of a patient. The doctor can talk to the operator to advise on the condition and treatment of the patient.
Patent IL-135458-A0 (IL)
Title: Human ribonuclease a with reduced ribonuclease inhibitor affinity
IPC: A61P35/00
Filed: 1998-10-13
Abstract: Modified ribonucleases belonging to the RNase A superfamily of ribonucleases is disclosed. Each modified ribonuclease has a mutation in the loop region corresponding to amino acids 85-94 of bovine pancreatic RNase A. Each modified ribonuclease has reduced binding affinity for ribonuclease inhibitor (RI), wild-type ribonuclease activity, and exhibits enhanced cytotoxicity toward tumor cells, relative to the wild-type ribonuclease. Also disclosed is a method for obtaining a modified ribonuclease having reduced binding affinity for RI, wild-type ribonuclease activity, and enhanced cytotoxicity.
Patent IL-142564-A0 (IL)
Title: Method and system for an extensible macro language
IPC: G06F17/30
Filed: 1999-10-15
Abstract: A method and system for an extensible macro language is provided. The system for providing the extensible macro language includes a parser and a macro handler for processing macro commands not previously defined in the macro language. The parser analyzes keywords in a macro language expression and recognizes one or more keywords representing macro commands that were not previously defined in the macro language. The macro handler receives the keywords in the macro expression and retrieves from a registry of keywords, an executable code or procedure associated with the keyword. The executable code is run to process the macro command represented by the keyword. The template language registry may be augmented to include any keywords and associated codes for extending the macro language.
Patent IL-143893-A0 (IL)
Title: Droplet deposition apparatus
IPC: B41J2/155
Filed: 1999-12-24
Abstract: Droplet deposition apparatus comprises an array of fluid chambers (300,310), each chamber communicating with an orifice for droplet ejection, a common fluid inlet manifold (220) and a common fluid outlet manifold (210,230), and means for generating a first fluid flow into the inlet manifold, through each chamber in the array and into the outlet manifold, the fluid flow through each chamber being sufficient to prevent foreign bodies in the fluid from lodging in the orifice. Each chamber is associated with means for effecting droplet ejection from the orifice resulting in a second fluid flow simultaneously with the fluid first flow through the chamber. The resistance to flow of one of the inlet and outlet manifolds is chosen such that the pressure at a fluid inlet to any chamber in the array varies between any two chambers by an amount less than that which would give rise to significant differences in droplet ejection properties between these two chambers. The first fluid flow is greater than the maximum value of the second fluid flow.
Patent IL-146994-A0 (IL)
Title: An efficient internet service implementation for mesh satellite networks
IPC: H04L12/56
Filed: 2000-06-14
Abstract: A centralized route-server architecture permits Internet Protocol (IP) services to be offered over satellite mesh networks. Individual satellite terminals perform forwarding of IP traffic to destination terminals based on routing information provided by the route-server. External routers connecting to terminals exchange OSPF and BGP routing protocol packets only with the central route-server.